Maverick Capital’s Globus Medical GMED Stock Holding History

Maverick Capital’s Portfolio GMED Stock Details GMED Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-15,660	Closed	-$1.35M	–	232
2026 Q1	$1.35M	Buy	+15,660	New	+$1.41M	0.02%	111
2022 Q1	–	Sell	-1,307	Closed	-$94K	–	293
2021 Q4	$94K	Sell	1,307 -9,226	-88%	-$670K	﹤0.01%	222
2021 Q3	$807K	Sell	10,533 -410	-4%	-$32.9K	0.01%	363
2021 Q2	$848K	Buy	+10,943	New	+$778K	0.01%	333

Other funds holding GMED

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Jupiter Topco New York $245B AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Kayne Anderson Rudnick Investment Management Los Angeles, California $32.2B AUM 10.98% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Sculptor Capital New York $12.3B AUM 40.26% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

Maverick Capital's GMED Position: Q2 2026 in Review

Maverick Capital sold out of Globus Medical (GMED) in Q2 2026, closing a stake of 15,660 shares — an estimated $1.35M sold.

Maverick Capital first reported a position in GMED in Q2 2021 and held it in 4 quarters. The position peaked at $1.35M in Q1 2026. 599 funds tracked by Wall St. Rank hold GMED as of Q2 2026.

Maverick Capital reported no remaining Globus Medical position as of Q2 2026 after selling out during the quarter.
Maverick Capital sold 15,660 Globus Medical shares in Q2 2026, an estimated $1.35M.
Maverick Capital first reported a position in Globus Medical in Q2 2021 and held it in 4 quarters.
Maverick Capital's Globus Medical position peaked at $1.35M in Q1 2026.
599 funds tracked by Wall St. Rank held Globus Medical as of Q2 2026.

Based on Maverick Capital's 13F filing for Q2 2026, filed 14 Aug 2026.